Company registration number: 2977135 Charity registration number: 1049067
## Wythenshawe Hospital Transplant Fund
(A company limited by guarantee)
Annual Report and Financial Statements
for the Year Ended 31 March 2023
## **Wythenshawe Hospital Transplant Fund**
## **Contents**
|Reference and Administrative Details|1|
|---|---|
|Trustees' Report|2 to 4|
|Statement of Trustees' Responsibilities|5|
|Independent Examiner's Report|6|
|Statement of Financial Activities|7 to 8|
|Balance Sheet|9|
|Notes to the Financial Statements|10 to 19|
|**Wythenshawe Hospital Transplant Fund**|**Wythenshawe Hospital Transplant Fund**|
|---|---|
|**Reference and Administrative Details**||
|**Trustees**|Dr P Callan|
||D K Cornwall|
||N Eadie|
||S Fowler|
||E Mather|
||W Noble|
||R Venkateswaran|
||J Haworth|
||R Wood|
||M J Hill|
|**Secretary**|L C Ellis|
|**Charity Registration Number**|1049067|
|**Company Registration Number**|2977135|
||The charity is incorporated in England and Wales.|
|**Principal Office**|The Transplant Fund Office|
||Transplant Centre|
||Wythenshawe Hospital|
||Manchester|
||M23 9LT|
|**Independent Examiner**|Maria Hallows BA (Econs), FCA, DCha|
||Chartered Accountant|
||Beever and Struthers|
||One Express|
||1 George Leigh Street|
||Manchester|
||M5 4DL|
|**Solicitors:**|Addleshaw Goddard|
||One St Peter's Square|
||Manchester|
||M2 3DE|
|**Bankers**|HSBC Bank plc|
||11 Stamford New Road|
||Altrincham|
||WA14 1BW|
||W H Ireland|
||11 St James's Square|
||Manchester|
||M2 6WH|
Page 1
## **Wythenshawe Hospital Transplant Fund**
## **Trustees' Report**
The trustees, who are directors for the purposes of company law, present the annual report together with the financial statements of the charitable company for the year ended 31 March 2023.
## **Trustees and officers**
The trustees and officers serving during the year and since the year end were as follows:
Trustees: Dr P Callan (appointed 22 June 2022) D K Cornwall N Eadie S Fowler E Mather W Noble R Venkateswaran J Haworth (appointed 30 January 2023) R Wood (appointed 30 January 2023) M J Hill (appointed 7 December 2023)
## **Objectives and activities**
## _**Objects and aims**_
In setting our objectives and planning our activities, the Trustees have given careful consideration to the Charity Commission’s general guidance on public benefit.
As determined by the charity's Memorandum and Articles of Association, the principal activity of the charity is to support the programme of heart and lung transplantation at Wythenshawe Hospital, Manchester, serving the North West of England. Whilst the NHS provides substantial funds for the transplant centre there is always a demand for state-of-the-art equipment or money to support pioneering treatments and research which the NHS is unwilling to fund. The charity plays a vital role by providing funds to accelerate the adoption of new procedures and by funding research which advances the technology surrounding transplantation, thus enabling the Wythenshawe Transplant Centre to remain at the forefront of excellence for the treatment of cardiac and lung disease.
The charity is in regular contact with Wythenshawe Hospital and receives funding requests from the hospital. The Board determines whether to meet these requests for funding. The charity does not enter into contractual relationships with suppliers of equipment and services. It only provides the agreed funding. The Trustees’ policy is to approve all major grants prior to commitment of funds. With the exception of minor funding of up to £5,000, which may be approved by the Chairman, decisions relating to the allocation of funds are reserved to the Board and cannot be delegated.
## _**Public benefit**_
All the activities of the charity are undertaken to further public benefit.
The trustees confirm that they have complied with the requirements of section 17 of the Charities Act 2011 to have due regard to the public benefit guidance published by the Charity Commission for England and Wales.
Page 2
## **Wythenshawe Hospital Transplant Fund**
## **Trustees' Report**
## **Achievements and performance**
Voluntary donations, legacies and other trading activities raised a total of £131,443 (2022: £198,166), grant income of £Nil (2022: £5,000) and investment income on our investments and cash deposits generated £24,530 (2022: £16,834). This allowed the Trustees to continue the charity's support for most of the requests submitted to the charity. Achievements within this financial year include, £21,000 given towards recipients selected to represent GB at the World Transplant Games, as well as contributions towards recipients attending the British Transplant Games, a £5,265 provision for free TV access to all beds on the Jim Quick Ward, a £3,249 purchase of Spirometers for use with our Lung recipients in Outpatients, and finally £27,245 spent on the purchase of more sherpa packs used for the transportation of Donor Hearts.
## **Financial review**
The results for the year and their impact on the Charity's funds are set out in detail in the Statement of Financial Activities. Total net income for the year was £94,195 (2022: £155,495) and the year end net assets amounted to £1,435,393 (2022: £1,341,198), including £1,444,152 (2022: £1,202,726) in cash at the bank or invested in UK Government Stocks, corporate bond funds and Open Ended Investment Companies.
## _**Policy on reserves**_
The charity's reserves are represented by its investments and cash balances. The Trustees have reviewed the charity’s requirements for unrestricted reserves in the light of the main risks to the organisation. In the opinion of the Trustees, sufficient unrestricted reserves are required to meet one year’s operating costs in the event of a significant drop in incoming resources and £50,000 is considered to be adequate for this purpose. The balance of the unrestricted reserves are free reserves and are available to be used to fund projects in accordance with the charity's objects.
At 31 March 2023 the unrestricted reserves were £1,422,039 (2022: £1,324,184). The trustees consider that the reserves held at the year end are above target level.
## _**Investment policy and objectives**_
The Trustees are empowered to invest and deal with the monies of the charity not immediately required in such a manner as the charity may from time to time determine subject to such conditions and consents imposed or required by law. Surplus funds are placed on deposit either with the charity's bankers or with W H Ireland Ltd or invested in UK Government Stocks, corporate bond funds and unit trusts. Investment returns are governed by the prevailing interest rates and dividend payments.
## **Structure, governance and management**
## _**Recruitment and appointment of trustees**_
No person may be appointed as a Trustee unless approved by all the Trustees. At every general meeting one third of the Trustees retire by rotation being decided by the length of time in office. Subject to the above, University Hospital of South Manchester NHS Foundation Trust (now Manchester University NHS Foundation Trust) may appoint one Trustee. Trustees must be aged 18 years or above and not disqualified by reason of Article 10.1 of the charity's Articles of Association or in company or charity law. None of the Trustees have any interest in the charity. Trustees are appointed under the provision of Articles 31 to 33 of the charity's Articles of Association.
## _**Induction and training of trustees**_
All new Trustees receive a formal briefing from the Chairman of their duties and responsibilities and receive various booklets from the Charity Commission and Companies House. Trustees are also encouraged to keep themselves abreast of current and proposed developments in charity regulation through access to the Charity Commission website and other relevant sources of information.
Page 3
## **Wythenshawe Hospital Transplant Fund**
## **Trustees' Report**
## _**Major risks and management of those risks**_
The Trustees continue to review the charity's activities to identify the major risks to which it is exposed and the systems established to mitigate risks are periodically reviewed to ensure that they are operating effectively and still meet the needs of the charity. It has been determined that the principal risks and uncertainties are the volatility of investments held by the charity and the continued ability to raise voluntary income. The steps taken by the Trustees to mitigate these risks as far as practicable are to maintain and regularly review a diversified portfolio of investments, to maintain sufficient cash reserves and to monitor both investment performance and the level of voluntary income received at each Board meeting.
## **Small companies provision statement**
This report has been prepared in accordance with the small companies regime under the Companies Act 2006.
The annual report was approved by the trustees of the charity on 29 January 2024 and signed on its behalf by:
......................................... D K Cornwall Trustee
Page 4
## **Wythenshawe Hospital Transplant Fund**
## **Statement of Trustees' Responsibilities**
The trustees (who are also the directors of Wythenshawe Hospital Transplant Fund for the purposes of company law) are responsible for preparing the trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".
Company law requires the trustees to prepare financial statements for each financial year. Under company law the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including its income and expenditure, of the charitable company for that period. In preparing these financial statements, the trustees are required to:
- select suitable accounting policies and apply them consistently;
- observe the methods and principles in the Charities SORP;
- make judgements and estimates that are reasonable and prudent;
- state whether applicable accounting standards, comprising FRS 102 have been followed, subject to any material departures disclosed and explained in the financial statements; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business.
The trustees are responsible for keeping proper accounting records that can disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Approved by the trustees of the charity on 29 January 2024 and signed on its behalf by:
**----- Start of picture text -----**
.........................................
D K Cornwall
Trustee
**----- End of picture text -----**
Page 5
## **Wythenshawe Hospital Transplant Fund**
## **Independent Examiner's Report to the trustees of Wythenshawe Hospital Transplant Fund ('the Company')**
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2023.
## **Responsibilities and basis of report**
As the charity’s trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
## **Independent examiner’s statement**
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
1. accounting records were not kept in respect of Wythenshawe Hospital Transplant Fund as required by section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view' which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
......................................
Maria Hallows BA (Econs), FCA, DCha Chartered Accountant
Beever and Struthers One Express 1 George Leigh Street Manchester M5 4DL
Date:.............................30 January 2024
Page 6
## **Wythenshawe Hospital Transplant Fund**
## **Statement of Financial Activities for the Year Ended 31 March 2023 (Including Income and Expenditure Account and Statement of Total Recognised Gains and Losses)**
|**Note**
**Income and Endowments from:**
Donations and legacies
3
Other trading activities
4
Investment income
5
Total income
**Expenditure on:**
Raising funds
6
Charitable activities
7
Total expenditure
Gains/losses on investment assets
Net income/(expenditure)
Net movement in funds
**Reconciliation of funds**
Total funds brought forward
Total funds carried forward
17|**Unrestricted**
**funds**
**£**
101,230
30,213
24,530
155,973
(8,969)
(10,885)
(19,854)
(38,264)
97,855
97,855
1,324,184
1,422,039|**Restricted**
**funds**
**£**
-
-
-
-
-
(3,660)
(3,660)
-
(3,660)
(3,660)
17,014
13,354|**Total**
**2023**
**£**
101,230
30,213
24,530|
|---|---|---|---|
||||155,973|
||||(8,969)
(14,545)|
||||(23,514)
(38,264)|
||||94,195|
||||94,195
1,341,198|
||||1,435,393|
The notes on pages 10 to 19 form an integral part of these financial statements. Page 7
## **Wythenshawe Hospital Transplant Fund**
## **Statement of Financial Activities for the Year Ended 31 March 2023 (Including Income and Expenditure Account and Statement of Total Recognised Gains and Losses)**
|**Note**
**Income and Endowments from:**
Donations and legacies
3
Other trading activities
4
Investment income
5
Total income
**Expenditure on:**
Raising funds
6
Charitable activities
7
Total expenditure
Gains/losses on investment assets
Net income
Net movement in funds
**Reconciliation of funds**
Total funds brought forward
Total funds carried forward
17|**Unrestricted**
**funds**
**£**
136,928
60,598
16,834
214,360
(8,038)
(75,622)
(83,660)
20,059
150,759
150,759
1,173,425
1,324,184|**Restricted**
**funds**
**£**
5,640
-
-
5,640
-
(904)
(904)
-
4,736
4,736
12,278
17,014|**Total**
**2022**
**£**
142,568
60,598
16,834|
|---|---|---|---|
||||220,000|
||||(8,038)
(76,526)|
||||(84,564)
20,059|
||||155,495|
||||155,495
1,185,703|
||||1,341,198|
All of the charity's activities derive from continuing operations during the above two periods. The funds breakdown for 2022 is shown in note 17.
The notes on pages 10 to 19 form an integral part of these financial statements. Page 8
## **Wythenshawe Hospital Transplant Fund**
## **(Registration number: 2977135) Balance Sheet as at 31 March 2023**
|**Note**
**Current assets**
Stocks
12
Debtors
13
Investments
14
Cash at bank and in hand
15
**Creditors: Amounts falling due within one year**
16
**Net assets**
**Funds of the charity:**
**Restricted income funds**
Restricted funds
**Unrestricted income funds**
Unrestricted funds
**Total funds**
17|**2023**
**£**
200
178
520,355
923,797
1,444,530
(9,137)
1,435,393
13,354
1,422,039
1,435,393|**2022**
**£**
200
240,324
551,809
650,917|
|---|---|---|
|||1,443,250
(102,052)|
|||1,341,198|
|||17,014
1,324,184|
|||1,341,198|
For the financial year ending 31 March 2023 the charity was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The trustees/directors have not required the charity to obtain an audit of its accounts for the year in question in accordance with section 476; and
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements on pages 7 to 19 were approved by the trustees, and authorised for issue on 29 January 2024 and signed on their behalf by:
**----- Start of picture text -----**
.........................................
D K Cornwall
Trustee
**----- End of picture text -----**
The notes on pages 10 to 19 form an integral part of these financial statements. Page 9
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2023**
## **1 Charity status**
The charity is a private company limited by guarantee, incorporated in England and Wales, and consequently does not have share capital. Each of the trustees is liable to contribute an amount not exceeding £1 towards the assets of the charity in the event of liquidation.
The address of its registered office is: The Transplant Fund Office Transplant Centre Wythenshawe Hospital Manchester M23 9LT
## **2 Accounting policies**
## **Summary of significant accounting policies and key accounting estimates**
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
## **Statement of compliance**
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)) (issued in October 2019) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
## **Basis of preparation**
Wythenshawe Hospital Transplant Fund meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes.
The financial statements are prepared in sterling, which is the functional currency of the entity.
## **Going concern**
The trustees consider that there are no material uncertainties about the charity's ability to continue as a going concern nor any significant areas of uncertainty that affect the carrying value of assets held by the charity.
## **Critical accounting judgements and key sources of estimation uncertainty**
The preparation of the financial statements in conformity with FRS 102 requires the use of certain critical accounting estimates. It can also require the Trustees to exercise their judgement in the process of applying the charity's accounting policies. The charity is not considered to have any critical accounting estimates or judgements at this time.
## **Income and endowments**
All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of the income receivable can be measured reliably.
Page 10
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2023**
## _**Donations and legacies**_
Donations are recognised when the charity has been notified in writing of both the amount and settlement date. In the event that a donation is subject to conditions that require a level of performance by the charity before the charity is entitled to the funds, the income is deferred and not recognised until either those conditions are fully met, or the fulfilment of those conditions is wholly within the control of the charity and it is probable that these conditions will be fulfilled in the reporting period.
Legacy gifts are recognised on a case by case basis following the grant of probate when the administrator/executor for the estate has communicated in writing both the amount and settlement date. In the event that the gift is in the form of an asset other than cash or a financial asset traded on a recognised stock exchange, recognition is subject to the value of the gift being reliably measurable with a degree of reasonable accuracy and the title to the asset having been transferred to the charity.
## _**Grants receivable**_
Grants are recognised when the charity has an entitlement to the funds and any conditions linked to the grants have been met. Where performance conditions are attached to the grant and are yet to be met, the income is recognised as a liability and included on the balance sheet as deferred income to be released.
## _**Investment income**_
Dividends are recognised once the dividend has been declared and notification has been received of the dividend due.
## **Expenditure**
All expenditure is recognised once there is a legal or constructive obligation to that expenditure, it is probable settlement is required and the amount can be measured reliably. All costs are allocated to the applicable expenditure heading that aggregate similar costs to that category. Where costs cannot be directly attributed to particular headings they have been allocated on a basis consistent with the use of resources, with central staff costs allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use. Other support costs are allocated based on the spread of staff costs.
## _**Raising funds**_
These are costs incurred in attracting voluntary income, the management of investments and those incurred in trading activities that raise funds.
## _**Charitable activities**_
Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them.
## **Taxation**
The charity is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.
## **Current asset investments**
Current asset investments are included at the lower of cost and net realisable value / market value.
Page 11
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2023**
## **Stock**
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell, after due regard for obsolete and slow moving stocks. Cost is determined using the first-in, first-out (FIFO).
## **Trade debtors**
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the charity will not be able to collect all amounts due according to the original terms of the receivables.
## **Cash and cash equivalents**
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
## **Fund structure**
Unrestricted income funds are general funds that are available for use at the trustees discretion in furtherance of the objectives of the charity.
Restricted income funds are those donated for use in a particular area or for specific purposes, the use of which is restricted to that area or purpose.
## **Financial instruments**
## _**Classification**_
Financial assets and financial liabilities are recognised when the charity becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the charity after deducting all of its liabilities.
Page 12
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2023**
## _**Recognition and measurement**_
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Financial assets and liabilities are only offset in the statement of financial position when, and only when there exists a legally enforceable right to set off the recognised amounts and the charity intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
Financial assets are derecognised when and only when a) the contractual rights to the cash flows from the financial asset expire or are settled, b) the charity transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or c) the charity, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.
Financial liabilities are derecognised only when the obligation specified in the contract is discharged, cancelled or expires.
## **3 Income from donations and legacies**
|Donations and legacies;
Donations from individuals
Legacies
In memoriam
Donations and legacies;
Donations from individuals
Legacies
In memoriam
Grants, including capital grants;
Grants from companies|**Unrestricted**
**funds**
**General**
**£**
45,264
64,991
26,673
-
136,928|**Unrestricted**
**funds**
**General**
**£**
43,627
35,226
22,377
101,230
**Restricted**
**funds**
**£**
640
-
-
5,000
5,640|**Total**
**2023**
**£**
43,627
35,226
22,377|
|---|---|---|---|
||||101,230|
||||**Total**
**2022**
**£**
45,904
64,991
26,673
5,000|
||||142,568|
Page 13
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2023**
## **4 Income from other trading activities**
|Trading income;
Income from sales of merchandise
Fundraising events
**5**
**Investment income**
Interest receivable and similar income;
Interest receivable on bank deposits
Other investment income|**Unrestricted**
**funds**
**General**
**£**
1,949
28,264
30,213
**Unrestricted**
**funds**
**General**
**£**
2,459
22,071
24,530|**Total**
**2023**
**£**
1,949
28,264
30,213
**Total**
**2023**
**£**
2,459
22,071
24,530|**Total**
**2022**
**£**
3,792
56,806|
|---|---|---|---|
||||60,598|
||||**Total**
**2022**
**£**
59
16,775|
||||16,834|
## **6 Expenditure on raising funds**
## **a) Costs of trading activities**
|Costs of goods sold|**Unrestricted**
**funds**
**General**
**£**
2,492
2,492|**Total**
**2023**
**£**
2,492
2,492|**Total**
**2022**
**£**
3,117|
|---|---|---|---|
||||3,117|
Page 14
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2023**
## **b) Investment management costs**
|Finance charges;
Bank charges
Other investment management costs;
Amounts payable to investment managers
**7**
**Expenditure on charitable activities**
Medical supplies / equipment
Refurbishment costs
Other charitable donations
Administration and other costs
Staff costs
Medical supplies / equipment
Other charitable donations
Administration and other costs
Staff costs|**Unrestricted**
**funds**
**General**
**£**
227
6,250
6,477
**Unrestricted**
**funds**
**General**
**£**
63,223
(89,719)
1,270
13,742
22,369
10,885
**Unrestricted**
**funds**
**General**
**£**
39,225
2,074
10,958
23,365
75,622|**Total**
**2023**
**£**
227
6,250
6,477
**Restricted**
**funds**
**£**
-
-
3,660
-
-
3,660
**Restricted**
**funds**
**£**
-
-
904
-
904|**Total**
**2022**
**£**
140
4,781|
|---|---|---|---|
||||4,921|
||||**Total**
**2023**
**£**
63,223
(89,719)
4,930
13,742
22,369|
||||14,545|
||||**Total**
**2022**
**£**
39,225
2,074
11,862
23,365|
||||76,526|
Page 15
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2023**
## **8 Net incoming/outgoing resources**
Net incoming resources for the year include:
|Finance charges payable
Independent Examiners Fee|**2023**
**£**
227
2,340|**2022**
**£**
140
2,340|
|---|---|---|
## **9 Trustees remuneration and expenses**
No trustees, nor any persons connected with them, have received any remuneration from the charity during the year.
No trustees have received any reimbursed expenses or any other benefits from the charity during the year.
## **10 Staff costs**
The aggregate payroll costs were as follows:
|**Staff costs during the year were:**
Wages and salaries
Pension costs
The monthly average number of persons (including senior management /
charity during the year expressed as full time equivalents was as follows:
Administrative Staff
No employee received emoluments of more than £60,000 during the year.
**11 Taxation**
The charity is a registered charity and is therefore exempt from taxation.
**12 Stock**
Stocks|**2023**
**£**
**2022**
**£**
21,074
21,750
1,295
1,615
22,369
23,365
leadership team) employed by the
**2023**
**No**
**2022**
**No**
1
1
**2023**
**£**
**2022**
**£**
200
200|**2022**
**£**
21,750
1,615|
|---|---|---|
|||23,365|
|||**2022**
**£**
200|
Page 16
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2023**
## **13 Debtors**
|Legacies receivable
Prepayments
Other debtors
**14 Current asset investments**
Listed other shares
**15 Cash and cash equivalents**
Cash at bank
**16 Creditors: amounts falling due within one year**
Other taxation and social security
Accruals|**2023**
**£**
-
177
1
178
**2023**
**£**
520,355
**2023**
**£**
923,797
**2023**
**£**
545
8,592
9,137|**2022**
**£**
231,139
184
9,001|
|---|---|---|
|||240,324|
|||**2022**
**£**
551,809|
|||**2022**
**£**
650,917|
|||**2022**
**£**
1,642
100,410|
|||102,052|
Page 17
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2023**
## **17 Funds**
|**Unrestricted funds**
General
**Restricted funds**
**Total funds**
**Unrestricted funds**
General
**Restricted funds**
**Total funds**|**Balance at 1**
**April 2022**
**£**
1,324,184
17,014
1,341,198
**Balance at 1**
**April 2021**
**£**
1,173,425
12,278
1,185,703|**Incoming**
**resources**
**£**
155,973
-
155,973
**Incoming**
**resources**
**£**
214,360
5,640
220,000|**Resources**
**expended**
**£**
(19,854)
(3,660)
(23,514)
**Resources**
**expended**
**£**
(83,660)
(904)
(84,564)|**Other**
**recognised**
**gains/(losses)**
**£**
(38,264)
-
(38,264)
**Other**
**recognised**
**gains/(losses)**
**£**
20,059
-
20,059|**Balance at**
**31 March**
**2023**
**£**
1,422,039
13,354|
|---|---|---|---|---|---|
||||||1,435,393|
||||||**Balance at**
**31 March**
**2022**
**£**
1,324,184
17,014|
||||||1,341,198|
The specific purposes for which the funds are to be applied are as follows:
The restricted income funds comprise amounts given by donors who indicate that their donations are to be spent on specific items to be used, or projects to be carried out, at Wythenshawe Hospital to further the objects of the charity. The balance at the year end can be split between equipment for hearts £4,090 (2022: £4,090), expenditure for the bungalows £7,923 (2022: £7,923), educational grant £1,340 (2022: £5,000).
Page 18
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2023**
## **18 Analysis of net assets between funds**
|**18 Analysis of net assets between funds**||||
|---|---|---|---|
|Current assets
Current liabilities
Total net assets
Current assets
Current liabilities
Total net assets|**Unrestricted**
**funds**
**General**
**£**
1,431,176
(9,137)
1,422,039
**Unrestricted**
**funds**
**General**
**£**
1,431,236
(102,052)
1,329,184|**Restricted**
**funds**
**£**
13,354
-
13,354
**Restricted**
**funds**
**£**
17,014
-
17,014|**Total funds at**
**31 March**
**2023**
**£**
1,444,530
(9,137)|
||||1,435,393|
||||**Total funds at**
**31 March**
**2022**
**£**
1,448,250
(102,052)|
||||1,346,198|
## **19 Related party transactions**
There were no related party transactions in the year.
Page 19